可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Rodriguez-Artalejo F,Banegas Banegas JR,Guallar-Castillon P.Epidemiology of heart failure[J].Rev Esp Cardiol,2004,57(2):163-170.
[2]Dickstein K,Vardas PE,Auricchio A,et al.2010 focused update of ESC Guidelines on device therapy iheartfailure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC Guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association[J].Eur J Heart Fail,2010,12(11):1143-1153.
[3]钱俊峰,姜民红,葛均波.我国慢性心力衰竭流行病学和治疗现状[J].中国临床医学,2009,5(16):700-703.
[4]Selim AJ,Fincke BG,Rogers WH,et al.Guideline-recommended medications:variation across medicare advantage plans and associated mortality[J].J Manag Care Pharm,2013,19(2):132-138.
[5]Stamp KD,Machado MA,Allen NA.Transitional Care Programs Improve Outcomes for Heart Failure Patients:An Integrative Review[J].J Cardiovasc Nurs,2014,29(2):140-154.
[6]Sochalski J,Jaarsma T,Krumholz HM,et al.What works in chronic care management:the case of heart failure[J].Health Aff,2009,28(1):179-189.